Psychemedics

Psychemedics Assets per Share

The Total Assets per Share of Psychemedics (PMDI) as of Oct 20, 2026 is 1.36 USD. In the previous year, Total Assets per Share was 2.02 USD — a change of -32.52% (lower).

Assets per Share

1.36USD

YoY

-32.52%

Last updated:

Total Assets per Share of Psychemedics is 2024 1.36 USD. Total Assets per Share of Psychemedics was 2023 2.02 USD. It decreases by -32.52% lower compared to the previous year.

The Psychemedics Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2017
4.34 USD
Jan 1, 2018
4.09 USD
Jan 1, 2019
4.51 USD
Jan 1, 2020
3.93 USD
Jan 1, 2021
3.53 USD
Jan 1, 2022
3.07 USD
Jan 1, 2023
2.02 USD
Jan 1, 2024
1.36 USD
The Psychemedics Assets per Share history
YEARAssets per ShareYoY
1.36USD-32.52%
2.02USD-34.20%
3.07USD-13.08%
3.53USD-10.21%
3.93USD-12.81%
4.51USD+10.25%
4.09USD-5.81%
4.34USD+5.91%
4.10USD+13.57%
3.61USD-8.47%
3.94USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp provides drug testing services analyzing hair samples for drug presence, offering historical usage patterns and approximate drug intake levels. The company charges customers a per-unit fee for each tested sample, including training for sample collection and storage of positive results. Their primary service targets clients needing drug testing solutions, particularly in sectors requiring regular monitoring of substance use. The firm's technology focuses on hair analysis to deliver detailed insights into drug consumption over time. Psychemedics Corp's revenue model is based on per-unit testing fees, with services including sample collection training and storage of positive samples. Customers pay for each sample tested, leveraging the company's hair analysis technology to monitor drug use patterns. The business operates within the drug testing services segment, serving clients who require reliable and historical data on substance abuse. The company's drug testing services are designed for customers seeking detailed historical data on drug use, with results indicating both the amount ingested and usage patterns over time. Psychemedics Corp generates income through fixed fees per sample tested, covering the full service including sample collection training and positive sample storage. Their focus remains on delivering accurate, long-term drug usage insights through hair analysis. Psychemedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psychemedics stock

Total Assets per Share of Psychemedics is 1.36 USD in 2024.

Total Assets per Share of Psychemedics changed from 2.02 USD to 1.36 USD, representing a -32.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Psychemedics since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Psychemedics

All Key Metrics — Psychemedics